Levofloxacin Actavis

Levofloxacin, the active ingredient in Levofloxacin Actavis, is a fluoroquinolone antibiotic presented as an ophthalmic preparation for ocular (subconjunctival) use. It treats bacterial eye infections such as conjunctivitis, keratitis, and corneal ulcers in patients requiring topical therapy.

GNH USA supplies Levofloxacin Actavis as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin Actavis is a fluoroquinolone antibiotic used to manage bacterial infections of the eye. - Bacterial conjunctivitis: reduces bacterial load and promotes resolution of infection. - Keratitis: eradicates causative bacteria and supports corneal healing. - Corneal ulcer: eliminates infection and aids in ulcer closure.

Levofloxacin Actavis may cause ocular and systemic adverse reactions.

Common Side Effects: - Eye irritation or burning sensation. - Redness of the conjunctiva. - Temporary blurred vision. - Mild headache. - Tearing or increased lacrimation. - Local allergic conjunctivitis.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis, angioedema). - Tendon rupture or tendinitis. - Central nervous system effects (seizures, dizziness). - Phototoxic skin reactions. - Development of resistant bacterial strains. - Corneal ulcer worsening despite therapy.

Levofloxacin Actavis should be used with attention to patient safety and proper handling. - Allergy assessment: avoid use in patients with known fluoroquinolone hypersensitivity. - Contact lens wearers: discontinue lenses during treatment to reduce irritation. - Systemic absorption: monitor patients with renal impairment for potential accumulation. - Pregnancy and lactation: prescribe only if benefits outweigh potential risks. - Storage: Store at room temperature: keep in original container, protect from light and moisture.

Levofloxacin Actavis may interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Systemic quinolones with antacids or multivitamins containing aluminum, magnesium, calcium, or iron (reduce absorption). - Concurrent use with warfarin (may increase INR and bleeding risk). - Co‑administration with corticosteroids (higher risk of tendon rupture).

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs) (potential for CNS stimulation). - Diabetic agents (may affect blood glucose control). - Other ophthalmic antibiotics (possible antagonism or reduced efficacy).